Reducing the risk of long-term heart problems later in life from cancer treatment – the role of proton beam therapy…
Publishing strategic priorities in radiotherapy research
'The NCRI Radiotherapy (CTRad) Group has published its strategic priorities in radiotherapy research to address challenges in the field and…
Publishing strategic priorities in breast cancer research
'The NCRI Breast Group has published its strategic priorities to address challenges faced in breast cancer research and improve outcomes…
NCRI’s CTRad to lead COVID RT to study the impact of COVID-19 on radiotherapy
'COVID RT is a national initiative that aims to study the impact of the COVID-19 pandemic on UK radiotherapy services…
Could drug treatment combined with targeted radiotherapy improve brain mets prognosis?
'Patients with brain metastases are an underserved population Brain metastases occur in 20-40% of all patients with cancer. Brain metastases…
Latest radiotherapy news from NCRI
'CTRad 10-year celebration at the 2019 NCRI Conference As part of CTRad’s 10-year anniversary celebrations, a session was hosted at…
Reducing the prostate cancer treatment burden on both patients and the health service
'Radiotherapy treatment for prostate cancer Standard radiotherapy for prostate cancer is an important and effective treatment, but until recently involved…
Interview with Prof David Sebag-Montefiore, new chair of NCRI’s CTRad
'David Sebag-Montefiore is an academic clinical oncologist at the University of Leeds and an honorary Clinical Oncologist at the Leeds…
CTRad’s Top 10 achievements
'NCRI’s CTRad celebrated its tenth year anniversary in 2019. To mark the occasion CTRad’s Executive Group identified the top 10…
The SMALL study for treating early-stage breast cancer
'The SMALL study is a phase 3 clinical trial, receiving over £2.3M in funding from the NIHR HTA, designed to…
The number one achievement over ten years of NCRI’s CTRad
'NCRI’s Radiotherapy Research Group (CTRad) is one of NCRI’s flagship initiatives and this year we are celebrating its ten year…
Investigating kinder treatments in head and neck cancer
'PATHOS is a trial investigating kinder treatments for head and neck cancer patients. It looks at treatment after surgery for…